Navigation Links
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Date:9/17/2011

ck) were enrolled. Of the 262 women who completed the parent study, 200 enrolled in the extension study, all of whom received Prolia (60 mg every 6 months). Results focused on patients who received Prolia treatment for up to eight years, where BMD showed gains at the lumbar spine and total hip of 16.8 percent and 6.9 percent, respectively, compared with their parent study baseline.

Osteoporosis: Impact and Prevalence

Referred to as a "silent epidemic" by the International Osteoporosis Foundation (IOF), osteoporosis is a global problem that is increasing in significance as the population of the world both increases and ages. The World Health Organization has officially declared osteoporosis a public health crisis, and the IOF is urging governments worldwide to make osteoporosis a healthcare priority.

Osteoporosis-associated fractures are a significant cause of mortality and morbidity. In 2000, the number of osteoporotic fractures in Europe was estimated at 3.79 million, of which 890,000 were hip fractures.(1) Since 2001, the incidence of hip fractures in European countries has risen significantly.(2) In the United States (U.S.), the number of fractures due to osteoporosis is expected to rise to more than three million by 2025.(3)

The direct medical cost of osteoporotic fractures in Europe is expected to rise from euro 31.7 billion in 2000 to  euro 76.7 billion in 2050.(4) In 2005, osteoporosis-related fractures were responsible for an estimated $19 billion in cost in the U.S., and this cost is expected to rise to approximately $25 billion by 2025.(5)

About Prolia

Prolia is the first approved therapy that specifically targets RANK Ligand, an essential regulator of osteoclasts (the cells that break down bone).

Prolia is approved in the U.S. for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
2. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
3. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
4. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
5. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
6. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
7. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
8. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
9. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... Calif. , July 7, 2015  Essentialis, a venture-backed ... agonists for the treatment of orphan neurobehavioral and metabolic diseases, ... and CSO, will present a corporate update at the Cantor ... Conference Date: Wednesday, July 8, 2015 Time: ... About Essentialis, Inc. ...
(Date:7/7/2015)... NEW YORK , July 7, 2015 ... new generation of drugs within human and veterinary oncology, ... the Securities and Exchange Commission, in connection with the ... the NASDAQ Stock Market. The number of American Depositary ... price range for the offering have not yet been ...
(Date:7/7/2015)... Ill. , July 7, 2015  Monopar Therapeutics ... oncology compounds, announced that its co-founder and CEO, ... British Council,s Education U.K. Alumni Entrepreneurial Award. The British ... China , India , and ... recognizes outstanding achievements made by entrepreneurs who have leveraged ...
Breaking Medicine Technology:Oasmia Pharmaceutical Files a Registration Statement on Form F-1/A for its Proposed Public Offering and an Application with NASDAQ for a US Listing and Announces Investor Roadshow 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 2Monopar Therapeutics Announces Founder And CEO Chandler Robinson Awarded The British Council's Education U.K. Alumni Award 3
... 2011 Scientists at Osel Inc . and ... a new way to prevent HIV infection by genetically ... block viral transmission. Bioengineered bacteria introduced into the vaginal ... of simian HIV (SHIV) by nearly two thirds. ...
... July 18, 2011 Data from high-risk patients requiring ... nondeferrable, non-cardiac surgery show good short- and long-term clinical ... according to a study published online on the journal ... In the single-center study, patients treated with the Genous ...
Cached Medicine Technology:Scientists Use Live Bacteria to Fight HIV 2Scientists Use Live Bacteria to Fight HIV 3OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 2OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery 3
(Date:7/7/2015)... ... ... Difass USA, a modern supplement brand committed to excellence, understands that sometimes ... knowing that there is hopefully a vacation to look forward to this summer. But ... a vacation can be quite stressful, and it’s difficult sometimes to fully disconnect and ...
(Date:7/7/2015)... MA (PRWEB) , ... July 07, 2015 , ... The ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition ... and other men who have sex with men (MSM) and transgender women, the ...
(Date:7/7/2015)... ... 2015 , ... SC&H Group, a leading audit, tax, and consulting firm, recently ... community through company-wide volunteering efforts. , On an annual basis, in coordination with ... in need throughout Baltimore and Washington D.C. , This year, SC&H Group’s ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... the experience for its patient community using its IDF ePHR, an electronic personal ... primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, diagnoses, ...
(Date:7/7/2015)... ... 07, 2015 , ... FSAstore.com today announced the launch of its ... makes it simple to use, spend and manage HSA funds with innovative tools including ... , According to a report by Devenir , approximately 13.8 million Americans have ...
Breaking Medicine News(10 mins):Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:SC&H Group Celebrates 9th Annual Day of Service 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 2Health News:Introducing HSAstore.com: A New E-commerce Site for Health Savings Account Eligible Products and Services 3
... The Providence Service,Corporation (Nasdaq: PRSC ) today announced ... Convertible Senior Subordinated Notes due in,2014. RBC Capital ... The private placement was priced off today,s closing ... annum and are convertible into,Providence common shares at a ...
... -- Net loss narrows to $2.6 million - record performance,-- Domestic open-heart revenues of $6.7 million - ... 2006, ... over third quarter 2006 ... quarter ...
... premiums written increase 21% over the ... quarterly results., FARMINGTON, Conn., Nov. 6 Darwin Professional,Underwriters, Inc. ... financial results for the third quarter ended September 30,2007. Highlights include: ... million. Third quarter gross premiums written ...
... Businesses, LEHIGH VALLEY, Pa., Nov. 6 Air ... in advanced discussions over Wacker,s,purchase of Air Products, shareholdings ... Air Products Polymers (APP), including APP,s,vinyl acetate-ethylene activities. Air ... As for WPS, Wacker owns 80 percent and Air ...
... first annual HealthSaver,Caffeinated Cities Survey, commissioned by ... found that the most caffeinated city in ... Phoenix and Atlanta. (Photo: http://www.newscom.com/cgi-bin/prnh/20071106/NYTU175 ... are San Francisco/Oakland, followed,closely by Philadelphia, New ...
... Calif., Nov. 6 The scant,details of the health ... and Senate President pro Tem Don Perata provides some,potential ... would,guarantee a windfall for private health insurance companies out ... to the Foundation for,Taxpayer and Consumer Rights (FTCR)., ...
Cached Medicine News:Health News:Providence Service Corporation Completes Private Placement of $70 Million of Convertible Senior Subordinated Notes 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 2Health News:AtriCure Reports Third Quarter 2007 Financial Results 3Health News:AtriCure Reports Third Quarter 2007 Financial Results 4Health News:AtriCure Reports Third Quarter 2007 Financial Results 5Health News:AtriCure Reports Third Quarter 2007 Financial Results 6Health News:AtriCure Reports Third Quarter 2007 Financial Results 7Health News:AtriCure Reports Third Quarter 2007 Financial Results 8Health News:AtriCure Reports Third Quarter 2007 Financial Results 9Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $8.4 Million for the Third Quarter 7Health News:Air Products in Advanced Discussions With Wacker Over Polymers Business 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 2Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 3Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 4Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 5Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 6Health News:Caffeine Survey Reveals Most, Least Caffeinated Cities 7Health News:The Good, the Bad, and the Ugly of the Nunez/Perata Health Plan 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: